Subtopic Deep Dive
ApoL1 Trypanolysis and Kidney Disease
Research Guide
What is ApoL1 Trypanolysis and Kidney Disease?
ApoL1 trypanolysis refers to the lytic activity of apolipoprotein L1 (ApoL1) variants against Trypanosoma brucei parasites, with high-risk variants (G1 and G2) conferring resistance to infection but increasing risk of focal segmental glomerulosclerosis (FSGS) in African ancestry populations.
Genovese et al. (2010) identified ApoL1 G1/G2 variants associated with kidney disease in African Americans (1981 citations). These variants evolved for trypanolytic protection against T. brucei but cause podocyte toxicity leading to FSGS. Over 20 papers link this dual role, with Cooper et al. (2017) showing contrasting trypanosomiasis resistance/susceptibility (125 citations).
Why It Matters
ApoL1 variants explain higher FSGS rates in African ancestry groups, affecting 5 million carriers worldwide and driving end-stage renal disease. Genovese et al. (2010) linked G1/G2 to non-diabetic kidney disease, guiding genetic screening. Cooper et al. (2017) revealed G1 resistance and G2 susceptibility to trypanosomiasis, informing infectious disease evolution. Thomson and Finkelstein (2015) detailed pH-gated channel mechanisms for trypanolysis, aiding drug design against trypanosomes.
Key Research Challenges
Balancing Resistance and Toxicity
ApoL1 G1/G2 variants protect against T. brucei but induce kidney cell cytotoxicity. Genovese et al. (2010) showed recessive risk for FSGS. Therapeutic modulation remains unresolved.
Trypanosome Evasion Mechanisms
T. b. gambiense resists ApoL1 via TgsGP gene, per Capewell et al. (2013, 66 citations). Understanding haptoglobin-hemoglobin receptor uptake blocks is key. Cooper et al. (2017) highlighted variant-specific effects.
Population Genetics Variability
G1/G2 frequencies vary across African populations, complicating disease modeling. Cooper et al. (2017) found contrasting trypanosomiasis associations. Capewell et al. (2014) described co-evolutionary arms race dynamics.
Essential Papers
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
Giulio Genovese, David J. Friedman, Michael D. Ross et al. · 2010 · Science · 2.0K citations
Out of Africa Kidney disease is more common in African Americans than in Americans of European descent, and genetics is likely to be a major contributing factor. Genovese et al. (p. 841 , published...
The animal trypanosomiases and their chemotherapy: a review
Federica Giordani, Liam J. Morrison, T.G. Rowan et al. · 2016 · Parasitology · 441 citations
SUMMARY Pathogenic animal trypanosomes affecting livestock have represented a major constraint to agricultural development in Africa for centuries, and their negative economic impact is increasing ...
Management of trypanosomiasis and leishmaniasis
Michael P. Barrett, S. L. Croft · 2012 · British Medical Bulletin · 302 citations
Improved diagnostic tools are needed to support treatment, for test of cure in clinical trials and for monitoring/surveillance of populations in control programmes.
APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis
Anneli Cooper, Hamidou Ilboudo, Vincent Pius Alibu et al. · 2017 · eLife · 125 citations
Reduced susceptibility to infectious disease can increase the frequency of otherwise deleterious alleles. In populations of African ancestry, two apolipoprotein-L1 (APOL1) variants with a recessive...
Clinical and Neuropathogenetic Aspects of Human African Trypanosomiasis
Peter G. E. Kennedy, Jean Rodgers · 2019 · Frontiers in Immunology · 125 citations
Trypanosomiasis has been recognized as a scourge in sub-Saharan Africa for centuries. The disease, caused by protozoan parasites of the <i>Trypanosoma</i> genus, is a major cause of mortality and m...
Human trypanolytic factor APOL1 forms pH-gated cation-selective channels in planar lipid bilayers: Relevance to trypanosome lysis
Russell Thomson, Alan Finkelstein · 2015 · Proceedings of the National Academy of Sciences · 124 citations
Significance African trypanosomes are parasites that can cause African sleeping sickness in humans. Host defense against some of these is provided by the human serum factor apolipoprotein L-1 (APOL...
The within-host dynamics of African trypanosome infections
Keith R. Matthews, Richard McCulloch, Liam J. Morrison · 2015 · Philosophical Transactions of the Royal Society B Biological Sciences · 96 citations
African trypanosomes are single-celled protozoan parasites that are capable of long-term survival while living extracellularly in the bloodstream and tissues of mammalian hosts. Prolonged infection...
Reading Guide
Foundational Papers
Start with Genovese et al. (2010) for ApoL1-kidney disease link (1981 citations), then Capewell et al. (2013) for T. b. gambiense resistance mechanisms; Thomson and Finkelstein (2015) details channel biophysics.
Recent Advances
Cooper et al. (2017) for variant-trypanosomiasis associations; Pays et al. (2022) reviews pathogenesis integrating ApoL1 evasion.
Core Methods
Genetic epidemiology (GWAS in Genovese et al., 2010), electrophysiology (bilayer channels, Thomson 2015), serum lysis assays (Capewell 2013), and co-evolutionary modeling (Capewell 2014).
How PapersFlow Helps You Research ApoL1 Trypanolysis and Kidney Disease
Discover & Search
Research Agent uses searchPapers and citationGraph to map ApoL1 literature from Genovese et al. (2010, 1981 citations) to Cooper et al. (2017); exaSearch uncovers structural studies, while findSimilarPapers links trypanolysis to FSGS variants.
Analyze & Verify
Analysis Agent applies readPaperContent on Genovese et al. (2010) abstracts, verifyResponse with CoVe for variant association claims, and runPythonAnalysis for citation trend stats or genetic frequency modeling; GRADE grading verifies evidence strength in trypanolytic mechanisms.
Synthesize & Write
Synthesis Agent detects gaps in ApoL1 toxicity modulation post-Cooper et al. (2017); Writing Agent uses latexEditText, latexSyncCitations for Genovese references, latexCompile for FSGS pathway figures, and exportMermaid for trypanolysis channel diagrams.
Use Cases
"Model ApoL1 G1/G2 allele frequencies in African populations vs. kidney disease risk"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas for allele stats from Genovese data) → matplotlib plot of risk curves.
"Draft review on ApoL1 trypanolysis mechanisms with citations"
Synthesis Agent → gap detection → Writing Agent → latexEditText → latexSyncCitations (Genovese 2010, Thomson 2015) → latexCompile → PDF review.
"Find code for ApoL1 structural simulations in trypanosome lysis"
Research Agent → paperExtractUrls (Thomson 2015) → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for channel modeling.
Automated Workflows
Deep Research workflow scans 50+ ApoL1 papers via citationGraph from Genovese et al. (2010), producing structured FSGS-try panolysis reports with GRADE scores. DeepScan applies 7-step CoVe verification to Cooper et al. (2017) claims on variant susceptibility. Theorizer generates hypotheses on ApoL1 engineering for trypanosome drugs without nephrotoxicity.
Frequently Asked Questions
What defines ApoL1 trypanolysis?
ApoL1 forms pH-gated cation channels lysing T. brucei lysosomes, as shown by Thomson and Finkelstein (2015). G1/G2 variants enhance this but risk kidney disease (Genovese et al., 2010).
What are key methods in ApoL1 research?
Genetic association studies (Genovese et al., 2010), planar lipid bilayer assays (Thomson and Finkelstein, 2015), and serum resistance gene sequencing (Capewell et al., 2013) characterize mechanisms.
What are seminal papers?
Genovese et al. (2010, 1981 citations) links variants to kidney disease; Cooper et al. (2017, 125 citations) shows trypanosomiasis associations; Capewell et al. (2013, 66 citations) identifies TgsGP resistance.
What open problems exist?
Developing ApoL1 variants safe for kidney function while potent against trypanosomes; resolving population-specific G1/G2 effects (Cooper et al., 2017); targeting TgsGP for therapy (Capewell et al., 2013).
Research Trypanosoma species research and implications with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching ApoL1 Trypanolysis and Kidney Disease with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.